QLT Visudyne
Executive Summary
FDA's Dermatologic & Ophthalmic Drugs Advisory Committee Ophthalmics Subcommittee will meet Nov. 17 to discuss QLT's verteporfin for the treatment of age-related macular degeneration. The committee will meet at the Holiday Inn in Bethesda, Md. beginning at 8:30 a.m